Toggle navigation
Home
Search
Services
Blog
Contact
About
In Vitro Screening of Chemopreventive Agents
Mehta, Rajendra
Iit Research Institute, Chicago, IL, United States
Search 52 grants from Rajendra Mehta
Search grants from Iit Research Institute
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Study of Health Effects of DDT in Mexico
B Cell Immunity to Influenza
Clinical Trial of Ibuprofen in Patients with Cystic Fibrosis
Neurosciences
Genetic Control of Mating in Yeast
Recently added grants:
Optimizing biologically-based rational polytherapy in ALK+ lung cancer
The Development of Organelle Specific Hsp90 Isoform-Selective Inhibitors
Structure-Function Investigation of Chemokine-GPCR Signaling in Tumor Progression and Metastasis
Coupling activation of primary sensory neurons as a novel plasticity mechanism for chronic pain
Lessons for Success
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN055502-001
Application #
3620792
Study Section
Project Start
1987-09-30
Project End
Budget Start
1987-09-30
Budget End
1988-12-29
Support Year
Fiscal Year
1987
Total Cost
Indirect Cost
Institution
Name
Iit Research Institute
Department
Type
DUNS #
005447826
City
Chicago
State
IL
Country
United States
Zip Code
60616
Related projects
NIH 1989
N01 CN
In Vitro Screening of Chemopreventive Agents
Mehta, Rajendra / Iit Research Institute
NIH 1988
N01 CN
Chemopreventive Agents in Dmba-Induced Mammary Lesions
Mehta, Rajendra / Iit Research Institute
NIH 1987
N01 CN
In Vitro Screening of Chemopreventive Agents
Mehta, Rajendra / Iit Research Institute
Publications
Mehta, R G; Moon, R C
(1991)
Characterization of effective chemopreventive agents in mammary gland in vitro using an initiation-promotion protocol.
Anticancer Res 11:593-6
Comments
Be the first to comment on Rajendra Mehta's grant